Skip to content
Menu

Vicore Pharma Holding AB (publ) VCRE

Full chart Compare
Set alert

Price alert · VCRE

All alert types
10.31 USD +0.15 (+1.48%)

As ofNov 17, 2026, 11:52 AM EST

10.21 Day range 10.24
7.88 52-week range 17.80
YTD
-36.55%
1 year
-36.55%

Revenue & Expenses

Revenue Profit Costs
Gross Profit$3.82MNet Loss$477.47MExpenses$481.29MSelling, General & Admin$67.91MResearch & Development$390.35MInterest Expense$60.00KOther Expenses$22.97MRevenue$3.82M

Latest period ending Dec 31, 2025 · select a line to chart its full history

VCRE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
3.82M109.35M0
3.82M109.35M0
-452.39M-194.19M-321.51M
-477.47M-168.63M-310.94M
-1.99-1.23-3.18
VCRE annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
578.15M1.16B—
1.19B1.18B—
98.05M54.56M—
1.10B1.13B—
VCRE annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023
-375.74M-164.95M-249.58M
-600.51M149.04M-144.46M
430.54M834.06M470.86M
-545.70M818.15M76.82M